porcin
circoviru
type
primari
caus
agent
emerg
swine
diseas
postwean
multisystem
wast
syndrom
pmw
antivir
treatment
avail
exploit
possibl
use
rna
interfer
rnai
therapeut
approach
diseas
plasmidborn
short
hairpin
rna
shrna
gener
target
genom
transfect
shrna
cultur
cell
caus
signific
reduct
viral
rna
product
accompani
inhibit
viral
dna
replic
protein
synthesi
infect
cell
effect
test
vivo
mous
model
develop
infect
mice
inject
shrna
infect
show
substanti
decreas
microscop
lesion
inguin
lymph
node
compar
control
situ
hybrid
immunohistochem
analys
show
shrna
caus
signific
inhibit
level
viral
dna
protein
synthesi
detect
lymph
node
treat
mice
rel
control
taken
togeth
result
indic
shrna
capabl
inhibit
infect
vitro
well
vivo
thu
may
constitut
effect
therapeut
strategi
infect
postwean
multisystem
wast
syndrom
pmw
new
emerg
diseas
affect
pig
primarili
week
age
diseas
first
identifi
within
highhealth
herd
western
canada
clark
consid
endem
mani
swineproduc
countri
world
allan
elli
pig
affect
pmw
show
weight
loss
dyspnea
tachypnea
anemia
diarrhea
jaundic
characterist
macroscop
find
enlarg
lymph
node
noncollaps
lung
tan
mottl
microscop
lesion
detect
number
tissu
characterist
lymphoid
tissu
lesion
consist
lymphocyt
deplet
follicular
interfollicular
area
togeth
macrophag
infiltr
lymphoid
tissu
common
lesion
describ
pmw
includ
interstiti
pneumonia
periport
diffus
hepat
interstiti
nephriti
clark
rosel
et
al
isol
viru
tissu
affect
pig
led
identif
porcin
circoviru
type
consid
etiolog
import
pmw
elli
et
al
hamel
et
al
meehan
et
al
morozov
et
al
porcin
circoviru
type
origin
identifi
contamin
porcin
kidney
cell
cultur
atcc
tischer
et
al
nonpathogen
pig
allan
et
al
tischer
et
al
porcin
circoviru
pcv
classifi
genu
circoviru
circovirida
famili
pringl
pcv
virion
icosahedr
nonenvelop
nm
diamet
genom
pcv
singlestrand
circular
dna
kb
overal
dna
sequenc
homolog
within
isol
greater
homolog
isol
two
major
open
read
frame
orf
recogn
pcv
call
rep
gene
encod
protein
kda
involv
viru
replic
mankertz
et
al
call
cap
gene
encod
major
immunogen
capsid
protein
kda
cheung
nawagitgul
et
al
addit
replicas
see
front
matter
elsevi
inc
right
reserv
capsid
protein
novel
protein
detect
product
infect
essenti
replic
cultur
cell
involv
virusinduc
apoptosi
liu
et
al
protein
demonstr
stimul
protect
respons
inject
pig
baculovirusexpress
product
dna
prepar
gene
blanchard
et
al
kamstrup
et
al
furthermor
studi
shown
chimer
viru
immunogen
capsid
gene
pathogen
clone
nonpathogen
genom
backbon
well
attenu
passag
could
induc
specif
antibodi
respons
fenaux
et
al
fenaux
et
al
howev
great
need
develop
new
therapi
infect
rna
interfer
rnai
natur
process
doublestrand
rna
direct
sequencespecif
posttranscript
gene
silenc
fire
hammond
et
al
b
sharp
specif
inhibit
endogen
pathogen
mrna
rnai
trigger
introduct
nucleotid
nt
duplex
rna
sirna
transcript
dna
precursor
short
hairpin
rna
shrna
homolog
target
sequenc
brummelkamp
et
al
elbashir
et
al
paddison
et
al
open
possibl
control
replic
process
pathogen
discoveri
promot
use
rnai
specif
inhibit
gene
express
replic
infecti
virus
past
year
rnai
approach
shown
effect
varieti
virus
cell
cultur
among
promin
virus
human
immunodefici
viru
capodici
et
al
influenza
viru
ge
et
al
polioviru
gitlin
et
al
sever
acut
respiratori
syndrom
viru
wang
et
al
herp
viru
jia
sun
human
papillomaviru
hamel
et
al
dengu
viru
caplen
et
al
west
nile
viru
mccown
et
al
synthet
sirna
well
shrna
transcrib
vivo
dna
templat
shown
potent
inhibitor
gene
express
adult
mice
mccaffrey
et
al
studi
mice
inject
shrna
sirna
direct
hepat
b
viru
rais
expect
use
rnai
antivir
strategi
giladi
et
al
mccaffrey
et
al
furthermor
sirna
dna
vector
produc
shrna
also
shown
reduc
influenza
viral
load
murin
lung
increas
surviv
ge
et
al
tompkin
et
al
recent
report
administr
sirna
mice
west
nile
viru
infect
reduc
viral
load
offer
partial
protect
lethal
infect
bai
et
al
demonstr
caus
lymphoid
lesion
infect
balbc
mice
character
expans
germin
center
lymphoid
organ
larg
number
histiocyt
cell
lymphoblast
apoptosi
histiocyt
cell
lymphoid
deplet
kiupel
et
al
consist
pig
therefor
model
system
offer
opportun
test
abil
rnai
inhibit
replic
vivo
report
shrna
direct
region
capabl
effici
inhibit
viral
replic
protein
synthesi
cell
cultur
system
well
mous
model
inhibit
viral
protein
synthesi
cell
cultur
shrna
sequencespecif
dosedepend
test
whether
rnai
could
inhibit
cell
cultur
gener
six
shrnaexpress
plasmid
target
region
genom
fig
abil
suppress
express
viral
protein
cell
transfect
shrnaexpress
plasmid
infect
level
viral
protein
product
determin
ifa
h
infect
time
point
measur
effect
shrna
cell
chosen
follow
preliminari
optim
experi
data
shown
confirm
specif
inhibit
shrnaexpress
plasmid
direct
porcin
parvoviru
viral
sequenc
use
neg
control
experi
result
show
shrnaexpress
plasmid
target
genom
caus
decreas
antigen
level
vari
degre
fig
c
among
specif
shrna
exhibit
highest
level
inhibit
fig
c
therefor
chose
two
shrnaexpress
plasmid
follow
experi
contrast
shrna
control
effect
antigen
level
treat
cell
indic
inhibit
shrna
specif
due
rnai
dose
respons
analysi
fig
conduct
transfect
cell
increas
amount
neg
control
plasmid
follow
measur
number
antigen
cell
ifa
h
posttransfect
result
show
concentr
ng
shrnaexpress
plasmid
per
cell
highest
level
inhibit
fivefold
viral
antigen
obtain
plasmid
wherea
effect
fig
higher
dose
shrna
observ
slight
nonspecif
inhibitori
effect
viral
protein
product
fig
addit
kinet
studi
result
fig
reveal
continu
trend
specif
inhibit
viral
product
h
transfect
inhibit
viral
product
maxim
h
thereaft
start
declin
h
transfect
confirm
effect
viral
product
reduct
rna
level
perform
realtim
rtpcr
analysi
rna
extract
cell
h
transfect
plasmid
respect
amount
viral
mrna
normal
gapdh
mrna
sampl
abund
mrna
significantli
reduc
cell
transfect
plasmid
fig
shrna
known
incorpor
rnainduc
silenc
complex
direct
rnainduc
silenc
complexmedi
sequencespecif
mrna
degrad
hammond
et
al
demonstr
contain
differ
mrna
mrna
level
reduc
cell
regardless
shrna
transfect
one
possibl
explan
effect
coordin
target
mrna
bound
shrna
might
affect
nontarget
mrna
viru
downstream
effect
viral
transcript
viral
replic
inhibit
detail
mechan
process
remain
unclear
studi
inhibitori
effect
plasmid
dna
replic
supernat
infect
cell
transfect
shrna
plasmid
h
posttransfect
directli
assay
pcr
amplif
primer
result
show
reduc
level
newli
synthes
viral
replic
form
rf
dna
observ
treat
cell
plasmid
fig
contrast
viral
rf
dna
detect
treat
cell
control
plasmid
seen
cell
fig
examin
abil
shrna
suppress
viral
gene
express
cell
singl
nucleotid
mutat
introduc
sequenc
shown
fig
cell
infect
transfect
shrnaexpress
plasmid
total
protein
extract
examin
immunoblot
analysi
mous
polyclon
antibodi
protein
h
postinfect
cell
transfect
plasmid
manifest
mark
deplet
viral
protein
compar
cell
transfect
plasmid
fig
extinct
protein
express
observ
plasmidtr
cell
signific
suppress
protein
express
notic
decreas
level
protein
detect
treatment
addit
drastic
suppress
detect
mutant
shrnaexpress
plasmid
depend
locat
mutat
rnai
sequenc
shown
fig
mutant
one
nucleotid
mutat
sens
strand
still
effect
reduct
synthesi
protein
wherea
nucleotid
substitut
center
sens
sequenc
result
shrna
fail
significantli
suppress
express
transfect
cell
verifi
specif
rnai
demonstr
amarzguioui
et
al
harborth
et
al
neither
viral
infect
treatment
shrna
alon
influenc
level
gapdh
product
fig
also
examin
effect
well
mutat
shrna
fac
porcin
antibodi
rais
h
shrnaexpress
plasmid
transfect
shown
fig
viral
product
significantli
reduc
cell
pretreat
plasmid
addit
significantli
suppress
protein
synthesi
wherea
two
shrna
mutant
effect
fig
indic
effect
shrna
inde
highli
specif
expect
shrna
also
inhibit
viral
express
fig
determin
whether
shrna
exert
antivir
respons
vivo
balbc
mice
administ
plasmid
day
viral
inocul
clinic
sign
gross
lesion
observ
shrnaexpress
plasmid
transfect
mocktransfect
mice
receiv
time
observ
period
microscop
alter
alon
mice
first
notic
day
postinfect
slight
germin
center
develop
parenchyma
inguin
lymph
node
data
shown
day
postinfect
mice
develop
promin
germin
center
consist
larg
lymphoblast
cell
histiocyt
cell
paracortex
loss
lymphocyt
infiltr
larg
number
histiocyt
fig
contrast
lymph
node
show
normal
microscop
morpholog
treat
mice
day
postinfect
seen
mockinfect
mice
data
shown
day
postinfect
mice
treat
show
significantli
lower
p
lesion
score
untreat
mice
show
consider
reduct
inguin
lymph
node
lesion
evidenc
decreas
lymphocyt
number
infiltr
histiocyt
compar
control
fig
c
addit
nonspecif
shrna
attenu
lymph
node
lesion
induc
infect
day
postinfect
data
shown
microscop
lesion
observ
mockinfect
mice
fig
result
suggest
shrna
significantli
attenu
lymph
node
patholog
mice
studi
effect
viral
dna
replic
vivo
perform
situ
hybrid
analysi
inguin
lymph
node
mice
treat
shrna
day
inject
replic
genom
dna
present
infect
cell
inguin
lymph
node
section
mice
receiv
alon
day
inject
slight
inhibitori
effect
observ
mice
data
shown
day
postinject
nucleic
acid
detect
infect
cell
macrophag
histiocyt
occasion
lymphocyt
inguin
lymph
node
tissu
section
mice
inocul
alon
posit
cell
typic
exhibit
dark
purpl
black
reaction
product
cytoplasm
well
nucleu
fig
b
lymph
node
section
mice
receiv
significantli
reduc
number
posit
cell
p
stain
cell
fig
number
stain
cell
section
mice
also
significantli
reduc
p
infect
cell
fig
contrast
number
posit
cell
section
mice
treat
rnai
show
reduct
p
fig
stain
seen
section
mockinfect
mice
fig
result
demonstr
shrna
inhibit
dna
replic
vivo
also
assess
effect
shrna
protein
synthesi
immunohistochem
stain
inguin
lymph
node
section
mice
treat
experi
describ
day
inject
shrna
follow
inocul
number
cell
stain
posit
group
slight
inhibitori
effect
observ
mice
data
shown
shown
fig
b
number
antigenposit
cell
increas
significantli
inguin
lymph
node
virusinocul
cell
day
inject
p
mice
treat
exhibit
small
increas
antigenposit
cell
treatment
fig
thu
overal
signific
inhibit
p
compar
virusinocul
alon
mice
stain
detect
mainli
cytoplasm
nucleu
well
control
mice
treat
show
similar
cell
viru
control
day
inject
fig
stain
seen
section
mice
inocul
fig
result
emphas
signific
antivir
activ
abil
suppress
protein
synthesi
vivo
rnai
oper
posttranscript
level
suppress
gene
express
develop
power
method
downregul
express
endogen
well
exogen
sequenc
cell
mcmanu
sharp
morri
et
al
abil
silenc
mammalian
gene
express
use
sirna
open
new
excit
rout
understand
mammalian
cell
biolog
patholog
mani
preced
rnai
effect
wide
rang
viral
pathogen
vitro
addit
rnai
demonstr
function
mice
inhibit
viral
replic
express
inject
specif
sirna
hepat
b
influenza
virus
ge
et
al
giladi
et
al
mccaffrey
et
al
uprichard
et
al
studi
shown
rnai
potenti
use
therapeut
prophylact
mechan
virus
provid
evid
shrna
target
region
capabl
inhibit
step
infect
cultur
cell
support
viral
product
vivo
mous
model
three
orf
region
recogn
studi
test
region
genom
effect
site
sirna
target
six
differ
shrna
select
gene
import
function
viral
replic
product
respect
test
effect
vectorbas
sirna
inhibit
replic
cultur
cell
found
six
shrna
could
caus
decreas
replic
vari
degre
two
effect
result
may
due
differ
posit
access
caus
steric
hindranc
secondari
tertiari
structur
andor
protein
bind
kamstrup
et
al
also
notic
nonspecif
plasmid
inhibitori
effect
replic
transfect
higher
concentr
could
due
nongenespecif
suppress
sirna
higher
concentr
sirna
demonstr
exhibit
measur
nonspecif
gene
suppress
activ
persengiev
et
al
therefor
identifi
highli
activ
sirna
decreas
sirna
concentr
allevi
nonspecif
effect
maintain
effici
silenc
thought
sirna
target
mrna
contain
sequenc
induc
cleavag
studi
use
realtim
rtpcr
detect
mrna
level
transfect
plasmid
found
shrna
significantli
reduc
correspond
mrna
level
inhibit
viral
gene
transcript
well
fig
could
relat
life
cycl
viru
assum
shrna
first
recogn
correspond
sequenc
viral
mrna
initi
degrad
mrna
consequ
degrad
mrna
result
blockag
correspond
protein
synthesi
ie
silenc
viral
gene
express
thu
amount
newli
synthes
matur
virion
might
reduc
subsequ
viru
infect
therefor
signific
inhibit
mrna
level
could
due
reduct
newli
synthes
matur
virion
induc
shrna
directli
target
mrna
hypothesi
confirm
data
viral
dna
reduc
supernat
transfect
cell
fig
protein
synthesi
inhibit
transfect
cell
fig
role
sirna
target
recognit
examin
employ
divers
sirna
nucleotid
substitut
amarzguioui
et
al
chiu
rana
elbashir
et
al
harborth
et
al
pusch
et
al
introduc
singl
nucleotid
chang
sirna
sequenc
could
abrog
sirnamedi
silenc
clarifi
question
perform
evalu
use
seri
mutant
contain
point
mutat
differ
locat
data
fig
c
suggest
point
mutat
middl
sequenc
sens
strand
could
elimin
activ
probabl
due
decreas
affin
sirna
target
mrna
schwarz
et
al
wherea
point
mutat
sequenc
interfer
antivir
activ
sequenc
specif
sirna
stringent
singl
base
pair
mismatch
sirna
target
sequenc
dramat
reduc
silenc
capabl
elbashir
et
al
elbashir
et
al
yuan
et
al
howev
molecular
mechan
phenomenon
need
studi
addit
demonstr
escap
mutant
gener
follow
sirna
shrna
treatment
gitlin
et
al
gitlin
et
al
prevent
treatment
multiplex
specif
sirna
target
long
portion
viral
genom
studi
also
perform
three
passag
newli
plasmidtransfect
cell
investig
whether
escap
mutant
gener
detect
mutant
data
shown
suggest
target
sequenc
critic
site
fit
viru
therefor
kind
target
sequenc
use
target
design
sirna
therapi
studi
address
potenti
sirnabas
therapeut
vivo
use
model
anim
system
interfer
transgen
endogen
gene
express
mice
follow
administr
sirna
duplex
report
mccaffrey
et
al
song
et
al
prolong
express
sirna
plasmid
integr
viral
vector
express
endogen
sirna
use
achiev
purpos
mccaffrey
et
al
uprichard
et
al
vectorbas
strategi
gener
sirna
may
use
test
inhibit
suppress
viral
gene
express
replic
anim
model
permit
greater
understand
role
activ
viral
gene
vivo
contrast
capabl
replic
balbc
mice
caus
microscop
lesion
kiupel
et
al
quintana
et
al
report
microscop
lesion
compat
infect
pig
detect
inocul
mice
might
due
inoculum
dosag
administr
rout
quintana
et
al
present
studi
observ
enlarg
germin
center
infiltr
larg
number
lymphoblast
histiocyt
cell
apoptosi
histiocyt
lymphocyt
deplet
paracortex
lymph
node
balbc
mice
fig
data
shown
resembl
earli
lesion
lymph
node
gnotobiot
pig
furthermor
replic
confirm
amount
viral
dna
protein
synthesi
lymph
node
fig
well
tissu
data
shown
mice
therefor
use
balbc
mice
anim
model
inhibit
infect
rnai
vivo
studi
describ
herein
show
rnai
induc
plasmidborn
small
interf
rna
use
inhibit
replic
porcin
pathogen
mous
model
system
day
inject
antivir
treatment
decreas
viral
express
inguin
lymph
node
attenu
lymph
node
lesion
mice
thu
may
applic
therapeut
strategi
natur
occur
infect
conclus
show
shrna
design
induc
antivir
effect
dna
replic
protein
synthesi
cultur
cell
anim
model
data
demonstr
rnai
potenti
prophylaxi
therapi
infect
perman
cell
line
free
pcv
maintain
minim
essenti
medium
mem
gibco
supplement
heatinactiv
fetal
bovin
serum
fb
lglutamin
uml
penicillin
g
al
ml
streptomycin
c
humidifi
co
incub
viru
strain
bjw
liu
et
al
use
studi
mammalian
express
vector
rnaireadi
psiren
psir
clontech
bd
use
express
sirna
six
specif
shrna
express
plasmid
construct
target
gene
strain
bjw
genbank
access
genom
target
sequenc
nt
nt
nt
nt
nt
nt
fig
suffix
f
r
oligonucleotid
indic
orient
target
sequenc
f
indic
forward
direct
nt
r
indic
revers
direct
nt
nonspecif
shrna
express
vector
target
capsid
protein
gene
porcin
parvoviru
construct
neg
control
sequenc
analyz
blast
search
genbank
databas
avoid
similar
sequenc
found
gene
share
homolog
within
publish
strain
well
oligonucleotid
synthes
insert
psir
vector
bamhi
ecori
site
accord
manufactur
instruct
transfect
shrna
perform
optim
condit
briefli
cell
seed
grown
c
overnight
cell
reach
confluenc
transfect
shrna
express
plasmid
lipofectamin
reagent
invitrogen
follow
h
transfect
cell
wash
infect
strain
bjw
indic
multipl
infect
moi
h
cell
overlaid
complet
medium
incub
c
co
cell
addit
treat
mm
dglucosamin
h
infect
describ
previous
tischer
et
al
h
postinfect
analyz
ifa
supernat
cell
lysat
collect
pcr
analysi
western
blot
respect
h
posttransfect
shrna
express
plasmid
cell
grown
plate
incub
min
c
moi
tcid
ad
mem
incub
follow
incub
c
cell
h
postinfect
wash
pb
fix
min
room
temperatur
rt
paraformaldehyd
pfa
pb
fixat
cell
block
pb
bsa
rt
h
primari
antibodi
porcin
antibodi
dilut
pb
bsa
incub
cell
h
c
wash
pb
cell
incub
rabbit
antiporcin
fluorescein
isothiocyan
fitc
conjug
antibodi
sigma
dilut
pb
bsa
h
c
cell
wash
three
time
pb
examin
use
fluoresc
microscop
cell
posit
viral
antigen
count
six
field
view
cell
harvest
fix
min
pfa
solut
nonspecif
bind
reduc
exposur
equin
serum
min
three
wash
fluorescenceactiv
cell
sorter
fac
wash
buffer
phosphatebuff
salin
fetal
calf
serum
sodium
azid
prior
incub
dilut
porcin
antibodi
min
rt
cell
wash
three
time
fac
buffer
incub
rt
dilut
fitcconjug
antiswin
igg
sigma
min
incub
cell
wash
three
time
fac
buffer
resuspend
al
fac
buffer
acquisit
analysi
facscalibur
instrument
becton
dickinson
use
winmdi
softwar
purdu
univers
cytometri
laboratori
western
blot
analysi
perform
cell
harvest
centrifug
g
min
pellet
lyse
min
ice
al
lysi
buffer
mm
tri
hcl
ph
mm
nacl
mm
edta
ph
triton
glycerol
mm
pmsf
mm
dtt
agml
proteinas
inhibitor
cocktail
novagen
lysat
collect
centrifug
g
min
c
concentr
measur
twenti
microgram
total
cellular
protein
sampl
resolv
sdspolyacrylamid
gel
electrophoresi
sdspage
blot
onto
nitrocellulos
nc
membran
stratagen
semidri
transfer
cell
biorad
transblot
sd
membran
block
h
rt
block
buffer
tbst
mm
tri
hcl
ph
mm
nacl
contain
skim
milk
powder
prevent
nonspecif
bind
incub
mous
antibodi
liu
et
al
monoclon
antibodi
human
dehydrogenas
gapdh
chemicon
intern
inc
ca
usa
rt
h
membran
wash
three
time
tbst
incub
h
rt
horseradishperoxidaseconjug
antimous
secondari
antibodi
dako
dilut
block
buffer
wash
membran
react
tetrahydrochlorid
pierc
rockford
ill
usa
substrat
stop
distil
water
newli
synthes
viral
dna
cell
cultur
assay
pcr
elsewher
describ
cheung
briefli
supernat
infect
cell
transfect
shrnaexpress
plasmid
h
posttransfect
use
templat
pcr
amplif
sens
primer
antisens
primer
use
amplifi
dna
pcr
consist
initi
enzym
activ
step
c
min
follow
cycl
denatur
c
anneal
c
extens
c
min
final
extens
c
min
pcr
product
electrophores
agaros
gel
photograph
total
cell
rna
prepar
virusinfect
cell
h
transfect
shrnaexpress
plasmid
use
trizol
rna
extract
reagent
invitrogen
revers
transcript
rt
pcr
rna
sampl
incub
dnase
min
c
remov
contamin
viral
dna
follow
primer
use
sens
antisens
gapdh
cdna
revers
transcrib
total
rna
use
antisens
primer
firststrand
synthesi
system
amv
revers
transcriptas
kit
roch
quantit
realtim
pcr
perform
lightcycl
roch
amplif
protocol
follow
instruct
taqman
gold
pcr
kit
sampl
run
triplic
rel
amount
target
gene
mrna
normal
gapdh
mrna
sampl
fifti
balbc
mice
week
age
randomli
assign
five
room
anim
mice
group
uninocul
serv
neg
control
express
plasmid
ag
per
mous
inject
via
tail
vein
intramuscular
rout
mice
group
respect
mice
group
serv
posit
control
h
mice
group
inocul
intranas
interperiton
tcid
strain
bjw
anim
monitor
daili
clinic
sign
diseas
day
postinfect
five
mice
randomli
select
group
necropsi
inguin
lymph
node
collect
necropsi
process
histolog
examin
situ
hybrid
ish
well
immunohistochem
ihc
stain
histolog
examin
inguin
lymph
node
collect
fix
immers
pfa
fix
sampl
dehydr
embed
paraffin
wax
section
stain
hematoxylin
eosin
lymph
node
score
assess
deplet
lymphoid
cell
infiltr
histocyt
cell
andor
presenc
multinucl
cell
ish
oligoprob
use
demonstr
nucleic
acid
briefli
bp
dna
fragment
amplifi
use
pair
primer
specif
oligoprob
label
digoxigenin
dig
roch
deparaffin
rehydr
lymph
node
section
proteolyt
digest
agml
proteinas
k
pb
buffer
min
c
postfix
pfa
pb
min
c
acetyl
slide
prehybrid
hybrid
buffer
formamid
ssc
agml
denatur
salmon
sperm
dna
min
c
follow
overnight
hybrid
c
diglabel
dna
probe
concentr
ngml
posthybrid
wash
slide
incub
antidig
roch
al
dilut
buffer
fetal
calf
serum
mm
tri
hcl
mm
nacl
ph
overnight
c
slide
wash
incub
nitro
blue
tetrazoliumbcip
mixtur
color
develop
mount
examin
microscopi
ihc
polyclon
antibodi
use
detect
presenc
viral
antigen
briefli
tissu
section
deparaffin
rehydr
grade
alcohol
endogen
peroxidas
activ
inhibit
flood
slide
h
triton
xpb
min
block
normal
mous
serum
h
rt
slide
incub
purifi
antibodi
overnight
rt
follow
incub
secondari
biotinyl
antiswin
igg
h
rt
avidinbiotin
peroxidas
abc
method
pierc
il
usa
dilut
appli
h
rt
section
final
incub
diaminobenzidin
dab
hydrogen
peroxid
solut
min
counterstain
methyl
green
dehydr
mount
permount
fisher
scientif
inc
examin
microscop
result
present
averag
standard
deviat
standard
error
mean
indic
statist
comparison
made
use
student
test
differ
group
consid
signific
p
valu
